EMA Authorised: Apremilast Accord — Accord Healthcare S.L.U.

View source ↗

Summary

Accord Healthcare S.L.U. has been authorised in the EU for apremilast (Accord).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthritis
• Behcet Syndrome
• Oral Ulcers
• Psoriasis
• Psoriatic Arthritis

Drugs mentioned

• Apremilast (apremilast)

Snippet

Status: Authorised. Therapeutic area: Arthritis, Psoriatic;Psoriasis;Behcet Syndrome;Oral Ulcer. MAH: Accord Healthcare S.L.U.. Decision date: 11/06/2026